A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Pancreatic Ductal Adenocarcinoma
Related studies linked through entity extraction aliases.
Application of Intrahepatic Arterial Infusion Chemotherapy for Patients With High Risk of Liver Metastases After Pancreatic Cancer Surgery
- Status
- UNKNOWN
- Phase
- NA
Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC
- Status
- UNKNOWN
- Phase
- PHASE2
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
DC Vaccine in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.
- Status
- TERMINATED
- Phase
- PHASE1
CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Transabdominal Ultrasound With BR55 for Characterization of Pancreatic Lesions
- Status
- TERMINATED
- Phase
- PHASE2
A Trial of PEGPH20 in Combination With Avelumab in Chemotherapy Resistant Pancreatic Cancer
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
A Clinical Study of EUS-RFA for Inoperable Pancreatic Ductal Adenocarcinoma
- Status
- SUSPENDED
- Phase
- NA
Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms
- Status
- UNKNOWN
- Phase
- NA
Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
CPI-613 in Combination With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
IACS-010759 in Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2